Quick Takeaways: Why It Matters? The $100M Symbiotic Capital facility, with $30M already drawn, gives TARGAN flexible, non‑dilutive growth capital, resets its lender base, and underwrites faster global deployment of WingScan at a time when revenues are already more th...
Quick Takeaways: Why It Matters? BE-101’s move into pivotal field safety testing brings the poultry sector closer to a commercially viable, non-antibiotic solution for necrotic enteritis, addressing a major economic and welfare burden while aligning with global pressure to...
